Headquartered in the Netherlands, and founded as a spin-off from DSM Group in 2017, InnoSyn has built a strong position as a specialist provider of outsourced chemical process research and development services across different sectors with a specific focus on pharmaceuticals and flavours & fragrances. Leveraging innovative and cost-efficient technologies such as biocatalysis, flow chemistry and chemocatalysis, the Company assists customers in developing scalable routes for the production of new chemical compounds or addressing cost challenges associated with existing products. InnoSyn also offers manufacturing capacity (non-GMP) for specific chemical products or enzymes on pilot plant scale.
Buyout
Current
Europe
Majority
Pharma Services
2023
Status
Creation Date
Number of Employees
Investment Date
Fund Name